Loading...
Cobolimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting HAVCR2/TIM3/CD366, Cobolimab is an antibody drug against the TIM3 target.
Biosimilars
Human
Monoclonal
Human
HAVCR2/TIM3/CD366
Human
IgG4 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 2022215-65-0
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más